# OnCo record paper-decision-sorafenib-lancet-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-decision-sorafenib-lancet-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-decision-sorafenib-lancet-2014" ;
  schema:name "DECISION: sorafenib in radioactive iodine-refractory differentiated thyroid cancer"@en ;
  schema:description "Sorafenib was the first drug shown to delay progression in iodine-refractory differentiated thyroid cancer, adding about five months compared with placebo and opening the era of kinase inhibitors for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-decision-sorafenib-lancet-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(14)60421-9>, <https://pubmed.ncbi.nlm.nih.gov/24768112/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(14)60421-9> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Brose MS, Nutting CM, Jarzab B, et al." ;
  onco:cancers <https://onco.cc/cancers/follicular-thyroid-cancer/> ;
  onco:drugs <https://onco.cc/drugs/sorafenib/> ;
  onco:trials <https://onco.cc/trials/decision-sorafenib/> ;
  onco:journals <https://onco.cc/journals/lancet/> .